Fireside Chat: Creating Alignment in Immune Monitoring & Interpretation of Read Outs to Increase Investment Opportunities & Accurately Measure Clinical Efficacy
Time: 4:00 pm
day: Day Two
Details:
- Creating a robust, methodical protocol for monitoring and analysing immune response to enable investors to contextualise and compare therapeutic efficacy
- Ensuring appropriate read outs and biomarkers are selected for immune monitoring to accurately evaluate immunogenicity of neoantigen vaccines and cell therapies
- Determining a desired level of de novo and secondary immune response to quantify efficacy
